Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
Authors
Keywords
New oral anticoagulants, Dabigatran, Coagulation tests, Complications, Stroke, Intracranial bleeding, Gastrointestinal bleeding, Thrombolysis, Recommendations
Journal
Clinical Research in Cardiology
Volume 102, Issue 6, Pages 399-412
Publisher
Springer Nature
Online
2013-05-13
DOI
10.1007/s00392-013-0560-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reversal of antithrombotic agents
- (2012) Kenneth A. Bauer AMERICAN JOURNAL OF HEMATOLOGY
- Interpretation of Point-of-care INR Results in Patients Treated with Dabigatran
- (2012) Joanne van Ryn et al. AMERICAN JOURNAL OF MEDICINE
- Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran
- (2012) Joachim Stangier et al. BLOOD COAGULATION & FIBRINOLYSIS
- Dabigatran Etexilate
- (2012) Celeste B. Burness et al. DRUGS
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen Activator
- (2012) Ying Xian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reducing in-hospital delay to 20 minutes in stroke thrombolysis
- (2012) A. Meretoja et al. NEUROLOGY
- Determination of Rivaroxaban in Human Plasma Samples
- (2012) Job Harenberg et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran
- (2012) Robert G. Hart et al. STROKE
- Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model
- (2011) Anne Godier et al. ANESTHESIOLOGY
- Potential Inaccuracy of Point-of-Care INR in Dabigatran-Treated Patients
- (2011) Lawrence Baruch et al. ANNALS OF PHARMACOTHERAPY
- Warfarin Therapy Does Not Increase Risk of Symptomatic Intracerebral Hemorrhage in Eligible Patients After Intravenous Thrombolysis
- (2011) Dimitriy Levin ARCHIVES OF NEUROLOGY
- Fibrinolytic Treatment of Acute Ischemic Stroke for Patients on New Oral Anticoagulant Drugs
- (2011) Carl-Erik Dempfle et al. CEREBROVASCULAR DISEASES
- Fatal Intracerebral Hemorrhage Associated with Administration of Recombinant Tissue Plasminogen Activator in a Stroke Patient on Treatment with Dabigatran
- (2011) Ignacio Casado Naranjo et al. CEREBROVASCULAR DISEASES
- Anticoagulation With the Oral Direct Thrombin Inhibitor Dabigatran Does Not Enlarge Hematoma Volume in Experimental Intracerebral Hemorrhage
- (2011) Arne Lauer et al. CIRCULATION
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
- (2011) Elise S. Eerenberg et al. CIRCULATION
- As time goes by? The fallacy of thrombolysis in STEMI networks
- (2011) Wolfgang von Scheidt et al. Clinical Research in Cardiology
- Daily physical activity in adults with congenital heart disease is positively correlated with exercise capacity but not with quality of life
- (2011) Jan Müller et al. Clinical Research in Cardiology
- Urgent endoscopy is associated with lower mortality in high-risk but not low-risk nonvariceal upper gastrointestinal bleeding
- (2011) L. Lim et al. ENDOSCOPY
- Acutely Injured Patients on Dabigatran
- (2011) Bryan A. Cotton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis
- (2011) Raymond C.S. Seet et al. STROKE
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran
- (2011) Wei Zhou et al. STROKE
- Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran
- (2011) María Consuelo Matute et al. THROMBOSIS AND HAEMOSTASIS
- Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)
- (2011) Ola Dahl et al. THROMBOSIS AND HAEMOSTASIS
- Prospective Multicenter Trial Comparing Push-and-Pull Enteroscopy With the Single- and Double-Balloon Techniques in Patients With Small-Bowel Disorders
- (2010) Andrea May et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
- (2010) Shyam Prabhakaran ARCHIVES OF NEUROLOGY
- Editorial Comment
- (2010) CEREBROVASCULAR DISEASES
- Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Dabigatran
- (2010) Ann De Smedt et al. CEREBROVASCULAR DISEASES
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
- (2010) Michael Rud Lassen et al. LANCET
- Newly Identified Events in the RE-LY Trial
- (2010) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement
- (2010) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Editorial Board
- (2009) JOURNAL OF ARTHROPLASTY
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
- (2009) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study
- (2008) H. R. Buller et al. BLOOD
- Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial
- (2008) Craig S Anderson et al. LANCET NEUROLOGY
- Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
- (2008) Stephan A. Mayer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
- (2008) Bengt I. Eriksson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
- (2008) Michael R. Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started